Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yacov Ron

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Antimicrobial Agents and Chemotherapy|November 24, 2005
Human immunodeficiency virus type 1 latency model for high-throughput screeningSofiya Micheva-Viteva, Annmarie L Pacchia, Yacov Ron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibodyKathryn X Wang, Yufang F Shi, Yacov Ron, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2011
Post-transcriptionally regulated expression system in human xenogeneic transplantation modelsHui-Ling Rose Lee, Chiann-Chyi Chen, Timor Baasov, et al.
Journal of Biotechnology|September 19, 2006
A HIV-2-based self-inactivating vector for enhanced gene transductionSayandip Mukherjee, Hui-Ling Rose Lee, Annmarie L Pacchia, et al.
The Journal of Biological Chemistry|August 2, 2002
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesisPatrick K O'Neil, Guoli Sun, Hong Yu, et al.
Retrovirology|October 26, 2013
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replicationLeia K Miller, Yoshifumi Kobayashi, Chiann-Chyi Chen, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Journal of Virology|October 22, 2002
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spotsJianling Zhuang, Amanda E Jetzt, Guoli Sun, et al.
Stem Cell Research & Therapy|March 16, 2011
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmidChristopher D Krause, Lara S Izotova, Gwangwen Ren, et al.
Blood|February 27, 2010
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphomaGaofeng Fan, Matthew J Simmons, Sheng Ge, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Antimicrobial Agents and Chemotherapy|November 24, 2005
Human immunodeficiency virus type 1 latency model for high-throughput screeningSofiya Micheva-Viteva, Annmarie L Pacchia, Yacov Ron, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 10, 2009
Plasma osteopontin modulates chronic restraint stress-induced thymus atrophy by regulating stress hormones: inhibition by an anti-osteopontin monoclonal antibodyKathryn X Wang, Yufang F Shi, Yacov Ron, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 19, 2011
Post-transcriptionally regulated expression system in human xenogeneic transplantation modelsHui-Ling Rose Lee, Chiann-Chyi Chen, Timor Baasov, et al.
Journal of Biotechnology|September 19, 2006
A HIV-2-based self-inactivating vector for enhanced gene transductionSayandip Mukherjee, Hui-Ling Rose Lee, Annmarie L Pacchia, et al.
The Journal of Biological Chemistry|August 2, 2002
Mutational analysis of HIV-1 long terminal repeats to explore the relative contribution of reverse transcriptase and RNA polymerase II to viral mutagenesisPatrick K O'Neil, Guoli Sun, Hong Yu, et al.
Retrovirology|October 26, 2013
Proteasome inhibitors act as bifunctional antagonists of human immunodeficiency virus type 1 latency and replicationLeia K Miller, Yoshifumi Kobayashi, Chiann-Chyi Chen, et al.
Antimicrobial Agents and Chemotherapy|January 25, 2003
Toward the development of a virus-cell-based assay for the discovery of novel compounds against human immunodeficiency virus type 1Martin E Adelson, Annmarie L Pacchia, Malvika Kaul, et al.
Journal of Virology|October 22, 2002
Human immunodeficiency virus type 1 recombination: rate, fidelity, and putative hot spotsJianling Zhuang, Amanda E Jetzt, Guoli Sun, et al.
Stem Cell Research & Therapy|March 16, 2011
Efficient co-expression of bicistronic proteins in mesenchymal stem cells by development and optimization of a multifunctional plasmidChristopher D Krause, Lara S Izotova, Gwangwen Ren, et al.
Blood|February 27, 2010
Defective ubiquitin-mediated degradation of antiapoptotic Bfl-1 predisposes to lymphomaGaofeng Fan, Matthew J Simmons, Sheng Ge, et al.
Pageof 3